Panitumumab - an effective long-term treatment for patients with metastatic colorectal cancer and wild-type KRAS status

被引：4

作者：

Elez, Elena ^{[1
]}

Alsina, Maria ^{[1
]}

Tabernero, Josep ^{[1
]}

机构：

[1] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona 08035, Spain

来源：

CANCER TREATMENT REVIEWS | 2010年 / 36卷

关键词：

Metastatic colorectal cancer; Late-stage metastatic colorectal cancer; Panitumumab; Response; Skin toxicity; Diarrhoea; MANAGEMENT;

D O I：

10.1016/S0305-7372(10)70003-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：S15 / S16

页数：2

共 14 条

[1]

*AMG LTD, VECT PAN SUMM PROD C

[2]

The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer [J].

Bouche, Olivier ;

Beretta, Giordano Domenico ;

Garcia Alfonso, Pilar ;

Geissler, Michael .

CANCER TREATMENT REVIEWS, 2010, 36 :S1-S10

[3]

Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study [J].

Chibaudel, Benoist ;

Maindrault-Goebel, Frederique ;

Lledo, Gerard ;

Mineur, Laurent ;

Andre, Thierry ;

Bennamoun, Mostepha ;

Mabro, May ;

Artru, Pascal ;

Carola, Elisabeth ;

Flesch, Michel ;

Dupuis, Olivier ;

Colin, Philippe ;

Larsen, Annette K. ;

Afchain, Pauline ;

Tournigand, Christophe ;

Louvet, Christophe ;

de Gramont, Aimery .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) :5727-5733

[4]

Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab [J].

Jacobs, Bart ;

De Roock, Wendy ;

Piessevaux, Hubert ;

Van Oirbeek, Robin ;

Biesmans, Bart ;

De Schutter, Jef ;

Fieuws, Steffen ;

Vandesompele, Jo ;

Peeters, Marc ;

Van Laethem, Jean-Luc ;

Humblet, Yves ;

Penault-Llorca, Frederique ;

De Hertogh, Gert ;

Laurent-Puig, Pierre ;

Van Cutsem, Eric ;

Tejpar, Sabine .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5068-5074

[5]

Labianca R, 2006, J CLIN ONCOL S, V24, P3505

[6]

Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer [J].

Laurent-Puig, Pierre ;

Cayre, Anne ;

Manceau, Gilles ;

Buc, Emmanuel ;

Bachet, Jean-Baptiste ;

Lecomte, Thierry ;

Rougier, Philippe ;

Lievre, Astrid ;

Landi, Bruno ;

Boige, Valerie ;

Ducreux, Michel ;

Ychou, Marc ;

Bibeau, Frederic ;

Bouche, Olivier ;

Reid, Julia ;

Stone, Steven ;

Penault-Llorca, Frederique .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :5924-5930

[7]

*MERCK SER, ERB CET SUMM PROD CH

[8]

Mitchell EP, 2009, J CLIN ONCOL, V27

[9]

Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer [J].

Sartore-Bianchi, Andrea ;

Di Nicolantonio, Federica ;

Nichelatti, Michele ;

Molinari, Francesca ;

De Dosso, Sara ;

Saletti, Piercarlo ;

Martini, Miriam ;

Cipani, Tiziana ;

Marrapese, Giovanna ;

Mazzucchelli, Luca ;

Lamba, Simona ;

Veronese, Silvio ;

Frattini, Milo ;

Bardelli, Alberto ;

Siena, Salvatore .

PLOS ONE, 2009, 4 (10)

[10]

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors [J].

Segaert, S ;

Van Cutsem, E .

ANNALS OF ONCOLOGY, 2005, 16 (09) :1425-1433

← 1 2 →